Inclisiran For Cholesterol: Docs Call It Expensive, Bat For Cheaper Options (Lead)
New Delhi, Jan 14 (IANS) Even as India is set to soon launch promising new DCGI and US FDA-approved medicine Inclisiran to lower cholesterol and keep it low
Stay updated with breaking news from Drug Controller General. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
New Delhi, Jan 14 (IANS) Even as India is set to soon launch promising new DCGI and US FDA-approved medicine Inclisiran to lower cholesterol and keep it low
Even as India is set to soon launch promising new medicine called the DCGI and US FDA-approved Inclisiran to lower cholesterol and keep it low with just two doses a year, doctors while hailing the advance contend that the drug is expensive and ...
Even as India is set to soon launch promising new DCGI and US FDA-approved medicine Inclisiran to lower cholesterol and keep it low with just two doses a year, doctors, while hailing the advance, contend that the drug is expensive and stressed on better use of the much cheaper versions available.
Even as India is set to soon launch promising new DCGI and US FDA-approved medicine Inclisiran to lower cholesterol and keep it low with just two doses a year, doctors, while hailing the advance, contend that the drug is expensive and stressed ...
Of the 19 FDCs, in June, the Union government — on orders of the drug regulatory agency Central Drugs Standard Control Organisation (CDSCO) --- announced the ban on 14 FDCs after they were found to lack therapeutic relevance